COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04311697


Column Value
Trial registration number NCT04311697
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : Dec. 31, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Jonathan C Javitt, MD, MPH

Contact
Last imported at : Dec. 31, 2020, 12:31 a.m.
Source : ClinicalTrials.gov

Robert E Besthof, rbesthof@neurorxpharma.com (PI email not reported)

Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-03-17

Recruitment status
Last imported at : Feb. 28, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

inclusion criteria: - critical covid-19 with respiratory failure - physician determination that patient is on maximal conventional medical therapy

Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

pregnancy (pregnant women may apply for open label treatment under compassionate care ind age <18 years mechanical ventilation for more than 7 days in primary cohort. mechanical ventilation>21 days in the exploratory cohort mean arterial pressure < 65 mm hg with use of pressor per icu protocol irreversible condition (other than covid-19) with projected fatal course ecmo current or recent (within 30 d) enrollment in another investigational trial of anti-il6 drug; active diagnosis of acquired immune deficiency syndrome; transplant patients currently immunosuppressed; chemotherapy-induced neutropenia (granulocyte count <1000/mm3); cardiogenic shock; congestive heart failure - nyha class 3 or 4; recent myocardial infarction - within last 6 months and troponin > 0.5 anuria (urine output < 50 ml/d) or other signs of multi-organ failure severe liver disease with portal hypertension; recent stroke or head trauma within last 12 months increased intracranial pressure, or other serious neurologic disorder; liquid diarrhea more than 3x/day; defined as more than 3 non-bloody watery stools within a 24-hour period, requiring additional fluid and electrolyte supplementation

Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : July 26, 2023, midnight
Source : ClinicalTrials.gov

APR Applied Pharma Research s.a.

Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

United States

Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Severe/critical disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

7: Severe/critical disease at enrollment

Total sample size
Last imported at : July 26, 2023, midnight
Source : ClinicalTrials.gov

203

primary outcome
Last imported at : Sept. 15, 2021, 4:30 a.m.
Source : ClinicalTrials.gov

Resolution of Respiratory Failure (Alive and Free of Respiratory Failure)

Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 2/Phase 3

Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 154, "treatment_name": "Aviptadil", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]